PayloopPayloop
CommunityVoicesToolsDiscoverLeaderboardReportsBlog
Save Up to 65% on AI
Powered by Payloop — LLM Cost Intelligence
Tools/Recursion vs PathAI
Recursion

Recursion

ai-healthcare
vs
PathAI

PathAI

ai-healthcare

Recursion vs PathAI — Comparison

Overview
What each tool does and who it's for

Recursion

Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us

Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery. Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas Leveraging the Power of Patient Data in AI-Drug Discovery Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

PathAI

At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clini

At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma and pathology laboratories — aiming to provide invaluable insights for biomarker discovery and drug development, and to improve laboratory workflows. AISight® is a cloud-native intelligent enterprise workflow solution used by the world's leading laboratories and research centers to power their digital pathology workflows and AI applications. It serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable multiple histopathology use cases. board-certified pathologists in our proprietary pathologist contributor network annotations contributed, aiding the training and validation of our AI-based algorithms of top 15 BioPharma companies leverage our technology to transform pathology Our team is passionate about solving big challenges in healthcare and transforming the field of pathology with artificial intelligence. We’re looking for board-certified, US-based pathologists with strong surgical pathology skills to provide pathology interpretation services for research and development efforts at PathAI.

Key Metrics
—
Avg Rating
—
0
Mentions (30d)
0
—
GitHub Stars
—
—
GitHub Forks
—
—
npm Downloads/wk
—
—
PyPI Downloads/mo
—
Community Sentiment
How developers feel about each tool based on mentions and reviews

Recursion

0% positive100% neutral0% negative

PathAI

0% positive100% neutral0% negative
Pricing

Recursion

tiered

PathAI

tiered
Use Cases
When to use each tool

Recursion (1)

The future of TechBio
Features

Only in Recursion (10)

The future of TechBioLEARN HOWDecoding biology to radically improve livesBetter medicines, through novel insights and precision designDelivering for our partners3 key ingredients: data, models, and computeThe latest from RecursionGet In TouchGet InvolvedPolicies

Only in PathAI (5)

For BioPharmaFor Anatomic PathologyPathAI Receives FDA Clearance for AISight® Dx Platform for Primary DiagnosisJoin Our TeamJoin Our Contributor Network
Product Screenshots

Recursion

Recursion screenshot 1

PathAI

No screenshots

Company Intel
research
Industry
information technology & services
800
Employees
270
—
Funding
$358.7M
—
Stage
Debt Financing
Supported Languages & Categories

Recursion

AI/MLDeveloper Tools

PathAI

View Recursion Profile View PathAI Profile